News and Trends 30 Sep 2024 The race for a bird flu vaccine: milestones and breakthroughs …platform could be leveraged to rapidly provide a vaccine candidate targeting the specific pandemic influenza strain.” Pfizer’s phase 1 mRNA vaccine candidate encodes the hemagglutinin (HA) antigen of a pandemic… September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2025 Top biotech deals in June 2025 …was slashed earlier this year. Meanwhile, this is XOMA Royalty’s second purchase in a month after it snagged the monoclonal antibody mezagitamab from the Swedish company BioInvent for $20 million. … July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2022 BigHat Biosciences raises $75M to design safer, more effective antibodies A company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today (July 20) announced it has raised $75 million in funding. BigHat Biosciences’ series… July 20, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 10 Apr 2020 Coronavirus Pandemic Bites into European Cancer Research …which specializes in cancer immunotherapy, has temporarily halted patient recruitment into phase I clinical trials for two of its cancer drug candidates, a bispecific antibody and a monoclonal antibody. On… April 10, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2023 UCB myasthenia gravis drug given FDA approval …receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. Rozanolixizumab-noli injection for subcutaneous infusion is a humanized IgG4 monoclonal antibody that binds to the neonatal Fc receptor (FcRN), resulting in… June 27, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jul 2018 Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial BioArctic, based in Stockholm, has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial tested the antibody… July 9, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jul 2020 Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal …cells. Kiadis’ cell therapy complements Sanofi’s antibody drugs “because it provides a way to deliver cancer-attacking natural killer cells to patients,” Lahr said. The antibody drugs that Sanofi will combine… July 13, 2020 - 3 minutesmins - By David Wilson Share WhatsApp Twitter Linkedin Email
Interview 19 Aug 2022 How re-engineering antibodies can prevent allergies …allowing us to identify the sequences of individual IgE antibodies. Once we have those sequences, we can start the re-engineering process. We retain the portion of the IgE antibody that… August 19, 2022 - 9 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Interview 8 May 2017 Meet the co-developer of the first commercial mAb and gene therapy Sander van Deventer is now a managing partner at Forbion after playing a critical role in the development of the first commercial monoclonal antibody, Remicade, and the first market-approved gene… May 8, 2017 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
In Depth 22 Mar 2021 Can Immunotherapy Offer Hope for Parkinson’s Sufferers? …antibody binds,” said Wagner Zago, CSO of Prothena, which has its headquarters in Dublin. “We’ve learnt that to drive efficacy, it’s really important for the antibody to have a very… March 22, 2021 - 5 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
In Depth 5 Jun 2024 Evolving standards of care: new treatments for cervical cancer …came after the antibody drug conjugate showed overall survival (OS) benefit in patients who had previously been treated for cervical cancer. A 30% reduction in the risk of death compared… June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Feb 2018 This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease The FDA has awarded Orphan Drug Designation to GeNeuro’s antibody for the treatment of a rare autoimmune disease following promising Phase IIb results in multiple sclerosis patients. GeNeuro develops therapies… February 26, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email